我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

甲状腺激素对心血管系统的作用机制及临床应用(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
1999年第1期
页码:
39-41
栏目:
综述
出版日期:
1999-01-01

文章信息/Info

Title:
-
作者:
李 宏 综述　易定华 审校
第四军医大学西京医院心血管外科 西安 710032
Author(s):
-
关键词:
甲状腺激素　心功能
Keywords:
-
分类号:
-
DOI:
-
文献标识码:
-
摘要:
-
Abstract:
-

参考文献/References

［1］Klemperer JD, Ojamaa K, Klein I, et al. Thyroid hormone theray in cardiovascular disease. Prog Cardiovasc dis, 1996;329.

［2］Dillmann WH. Cardiac function in thyroid disease, clinical feacture and management considerations. Ann Thorac Surg ,1993; 56: 9.

[3]Khoury SF, Hoit BD,Dave V , et al. Effects of thyroid hormone on left ventricular performance and regulation of contractile and Ca2+-cycling protins in the baboon. Circ Res, 1996; 79(4) : 727.

[4]Patricia SC,Morisaot AS, Knowlton KV , et al. α-Adrenergic stimulation inhibits 3, 5,3-triiodothyronine-induced expression of the rat heart sarcoplasmic reticulum. End ocrinology , 1997;138 (1) : 114.

[5]Segal J ,Masalha S, Schwav H, et al. Acute effect of thyroid hormone in the rat heart: role of calcium. J Endocrinol,1996; 149 (1) : 73.

[6]Tielens ET, Forder JR, Chatham JC, et al. Acute L-triiodothyronine administration potentiates inotropic responses to β-adrenergic stimulation in the isolated perfused rat heart. Cardiovasc Res, 1996; 32 (2) : 306.

[7]Ojamaa K, Balkman C, Klein IL , Acute effects of triiodothyronine on arterial smooth muscle cells. Ann thorac Surg ,1993; 56: S61.

[8]Walker JD, Cranford FA , Spinale FG, et al. Pretreatment with 3. 5. 3-triiodothyronine. J thorac Cardiovasc Surg , 1995; 110(2) : 315.

[9]Walker JD, Cranford FA , Spinale FG, et al. 3. 5. 3-L-threonine pretreatment with cardioplegic arrest and chronic left ventricular dysfunction. Ann Thorac Cardiovasc Surg , 1995; 65 (2) :292.

[10]Dyke CM , Ding M , Abd-Elfattah AS, et al. Effects of triiodothyronine supplementation after myocardial ischemia. Ann Thorac Surg , 1993; 56 (2) : 215.

[11] Bennett-Guerrero E, Jiminez JL , White WD, et al. Caridovascular effects of intravenous triiodothyronine in patients undergoimg coronary artery bypass graft surgery. JAMM , 1996;275: 687.

[12]Novitzky D, Human PA , Coper DKC. Intropic effects of triiodothyronine following myocardiol ischemia and cardiopulmonary bypass. Ann Thorac Surg , 1991; 51: 10.

[13]Klemperer JD, Klein I, Gomez M , et al. Thyroid Homone treatment after coronary artery bypass surgery, N Engl J Med ,1995; 333: 1522.

[14] Mahaffey KW , Raya TE, Pennock GD, et al. Left ventricular performance and remodeling in rabbit after infarction. Circulation, 1995; 91: 794.

[15] Votapka TV , Canvasser DA , Pennington DG. Effect of triiodothyronine on graft function in a model of heart transplanation. Ann Throac Surg , 1996; 62 (1) : 78.

[16]Groarin JP, Cohen S, Riou B, et al. The effects of triiodo thyronine on hemodynamic status and cardiac function in potential heart donors. Anesth Analg , 1996; 83 (1) : 41.

[17]Klein I, Ojamaa K. Cardiovascular manifestations of endocrine disease. J Clin Endocrinol Metab, 1992; 75: 339.

[18]Moruuzi P,Dorin E,Agoston. Usefulness of L-thyronine to improved cardioac and exercise performance in idiopathic dilated cardiomyopathy. Am J Cardiol, 1994; 73: 374.

[19] Burmank D. Is triiodothyronine administration beneficial in patients undergoing coronary artery bypass surgery. JAMM ,1996; 275: 724.

备注/Memo

备注/Memo:
(收稿1998-04-10　修回1998-08-10)
更新日期/Last Update: 1999-01-01